Knowledge Center

Article / Jan 01, 2012

Carcinogenic pollutants in drug manufacturing

Authors:
  • Gyorgy Szekely
  • William Heggie
  • Boerje Sellergren
Source:
Magyar Kemikusok Lapja (2012), 67(2), 34-37

A review.

Also in the Knowledge Center

Related Content

Dry Powder Inhalation formulation development

Hovione has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more

Hovione certified as a Top Employer in all of its manufacturing sites

Press Release / Jan 18, 2024
Article
View

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more